R42 AI065015/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Vaxfectin-adjuvanted plasmid DNA vaccine improves protection and immunogenicity in a murine model of genital herpes infection.

Shlapobersky M, Marshak JO, Dong L, Huang ML, Wei Q, Chu A, Rolland A, Sullivan S, Koelle DM. Shlapobersky M, et al. J Gen Virol. 2012 Jun;93(Pt 6):1305-1315. doi: 10.1099/vir.0.040055-0. Epub 2012 Mar 7. J Gen Virol. 2012. PMID: 22398318 Free PMC article.

A Vaxfectin(®)-adjuvanted HSV-2 plasmid DNA vaccine is effective for prophylactic and therapeutic use in the guinea pig model of genital herpes.

Veselenak RL, Shlapobersky M, Pyles RB, Wei Q, Sullivan SM, Bourne N. Veselenak RL, et al. Vaccine. 2012 Nov 19;30(49):7046-51. doi: 10.1016/j.vaccine.2012.09.057. Epub 2012 Oct 4. Vaccine. 2012. PMID: 23041125 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2 results

Search Page

Filters